Work

An Open-Label, Multi-Center Phase 2 study to Assess the Safety and Efficacy of Burixafor (GPC-100) and Propranolol with G-CSF for the Mobilization of Hematopoietic Progenitor Cells in Patients with Multiple Myeloma

Year: 2026

Type: article

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.jtct.2025.12.306

Authors: Jack Khouri, Yosra M. Aljawai, Ah-Reum Jeong, Dr. Muthalagu Ramanathan, Gunjan L. Shah, Hyung C. Suh, John Hiemenz, Jonathan D Licht, William Clark, Luke P Akard, Ann Woolfrey, Devki Sukhtankar, Pina M. Cardarelli, Nina Caculitan

Institutions: Cleveland Clinic, The University of Texas MD Anderson Cancer Center, University of California San Diego, Moores Cancer Center, University of Massachusetts Chan Medical School, Memorial Sloan Kettering Cancer Center, Hackensack University Medical Center, University of Florida, UF Health Cancer Center, Virginia Commonwealth University, Franciscan Health Indianapolis, Medpace (United States)

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7127438156

FWCI:

Cites:

Cited by:

Related to: 10